To build a model that used routine clinical information to screen for anxiety and depression, Patten's group studied 828 MS ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

In recently published research in the journal Neurology, the team tracked records for 4,593 people living with multiple sclerosis from 2019 to 2020, 673 in rural areas and 3,920 in urban centers.

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...

Thus, masitinib's anti-mast cell properties, and possible effect on dendritic cells, may be particularly well adapted to the treatment of PPMS. A reduction of mast cell activity via the inhibitory ...

Patients with relapsing-remitting multiple sclerosis (RRMS) in England, Wales and Northern Ireland can now access treatment with Biogen's oral therapy Vumerity, after NICE recommended the drug for ...

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

Biogen's efforts to replenish its multiple sclerosis pipeline have suffered ... but even potentially offer a functional cure. Biogen licensed rights to InnoCare's drug in a deal whose total ...

Feb. 3, 2025 — Maternal vitamin D levels in the first trimester were related to both prenatal growth and pregnancy outcomes, according to a new study. Low vitamin D levels during the first ...

Early signs of multiple sclerosis can include blurry vision, muscle weakness, dizziness and fatigue, and unusual tingling or pain sensations. These early warning signs occur because of damage to the ...